Learn More
Invitrogen™ TAZ Monoclonal Antibody (2B3)

Description
Peptide Sequence: MPLHVKWPFP AVPPLTWTLA SSVVMGLVGT YSCFWTSEWA QAEAGPPGYP CPAGGILKLR HIWNLKLMRW TPAAADICFT KELHSHFFSL GKCVPVCRGD GVYQKGMDFI LEKLNHGDWV HIFPEGIGRL IAECHLNPII LPLWHVGEPG DGDREMASGV GGLGLPLVPG CPAPPHVWPS VHCAAGMNDV LPNSPPYFPR FGQKITVLIG KPFSALPVLE RLRAENKSAV EMRKALTDFI QEEFQHLKTQ AEQLHNHLQP GR.
Specifications
Specifications
| Antigen | TAZ |
| Applications | ELISA, Western Blot |
| Classification | Monoclonal |
| Clone | 2B3 |
| Concentration | 0.4 mg/mL |
| Conjugate | Unconjugated |
| Formulation | PBS with no preservative; pH 7.4 |
| Gene | TAZ |
| Gene Accession No. | Q16635 |
| Gene Alias | 2310058J06Rik; 2610021I22Rik; 5031411C02Rik; 9130012G04Rik; AW107266; AW552613; Barth syndrome); BTHS; C78399; cardiomyopathy, dilated 3A (X-linked); CMD3A; EFE; EFE2; endocardial fibroelastosis 2; FLJ27390; G4.5; HGNC:11577; LVNCX; OTTHUMP00000061673; protein G4.5; Tafazzin; tafazzin (cardiomyopathy, dilated 3A (X-linked); tafazzin (cardiomyopathy, dilated 3A (X-linked); endocardial fibroelastosis 2; Barth syndrome); Taz; Taz1; transcriptional coactivator with PDZ binding motif; transcriptional co-activator with PDZ-binding motif; transcriptional coactivator with PDZ-binding motif; transcriptional co-activator with PDZ-binding motif (TA)Z; transcriptional co-activator with PDZ-binding motif (TAZ); WW domain containing transcription regulator 1; WW domain-containing transcription regulator protein 1; Wwtr1; XAP-2; XX-FW83563B9.3 |
| Show More |
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.